Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis-Reference-Cited by-同舟云学术

Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis

Published:2007 Issue:7 Volume:56 Page:2129-2134
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

van der Bijl A. E.,Goekoop-Ruiterman Y. P. M.,de Vries-Bouwstra J. K.,ten Wolde S.,Han K. H.,van Krugten M. V.,Allaart C. F.,Breedveld F. C.,Dijkmans B. A. C.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference21 articles.

1. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: A longitudinal analysis

2. Factors predicting response to treatment in rheumatoid arthritis: The importance of disease duration

3. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies

4. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing withdrawal strategies for anti-TNF-α therapies in rheumatoid arthritis;Expert Opinion on Biological Therapy;2024-07-25

2. Prevalence and predictors of sustained remission/low disease activity after discontinuation of induction or maintenance treatment with tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic and scoping review;Arthritis Research & Therapy;2023-11-20

3. A subset of type-II collagen-binding antibodies prevents experimental arthritis by inhibiting FCGR3 signaling in neutrophils;Nature Communications;2023-09-23

4. Two-year Outcomes of Infliximab Discontinuation in Patients with Rheumatoid Arthritis: A Retrospective Analysis from a Single Center;Internal Medicine;2020-08-15

5. Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data;Rheumatology and Therapy;2020-02-29